Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center Adjuvant Trial of Outpatient Moderate-Dose Bolus Interleukin-2 for Renal Cancer

NCT00003604 is registered in ClinicalTrials.gov with Cancer Biotherapy Research Group as lead sponsor.

NCT NCT00003604
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003604 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center Adjuvant Trial of Outpatient Moderate-Dose Bolus Interleukin-2 for Renal Cancer
Lead sponsor
Cancer Biotherapy Research Group
Phase
Phase 2
Overall status
Unknown status
Start date
October 31, 1997
Completion date
Not reported
Enrollment
20 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

kidney cancer